key: cord-0835695-8ueg6biu authors: Backhaus, Insa; Hermsen, Derik; Timm, Jörg; Boege, Friedrich; Lübke, Nadine; Degode, Tobias; Göbels, Klaus; Dragano, Nico title: SARS-CoV-2 seroprevalence and determinants of infection in young adults: A population-based seroepidemiological study date: 2022-03-23 journal: Public Health DOI: 10.1016/j.puhe.2022.03.009 sha: f0db478621817735f2e042711137e5412335e316 doc_id: 835695 cord_uid: 8ueg6biu Objectives The majority of SARS-CoV-2 seroprevalence studies have focused on adults and high-risk populations and little is known about young adults. The objective of the present study is to provide evidence on the SARS-CoV-2 seroprevalence among young adults in Germany and to explore determinants associated with seropositivity in general and, specifically, with previously undetected infections. Study design A population-based SARS-CoV-2 seroprevalence study. Methods In November 2020, a population-based study on SARS-CoV-2 seroprevalence in young adults (aged 18-30 years) was conducted in a large German city. Serum samples were obtained to analyse the SARS-CoV-2 antibody status using the Elecsys® Anti-SARS-CoV-2 immunoassay (Roche Diagnostics, Mannheim, Germany). Descriptive statistics and odds ratios (ORs) of seropositivity and of previously undetected infections in relation to different determinants were calculated. Results Among 2186 participants, SARS-CoV-2 antibodies were detected in 72 individuals, equalling a test performance-adjusted seroprevalence of 3.1% (95% confidence interval [CI]: 2.4–4.0). Based on reported COVID-19 cases to the public health authority, a moderate under-ascertainment rate of 1.7 was calculated. Seropositivity was higher among individuals who sought COVID-19-related information from social media (OR: 1.83, 95% CI: 1.2–3.1) and undetected COVID-19 infections were more prevalent among men and those not adhering to social distancing. Conclusions Results show a substantial under-ascertainment of SARS-CoV-2 infections among young adults and indicate that seroprevalence is likely to be much higher than the reported COVID-19 prevalence based on confirmed COVID-19 cases in Germany. Preventive efforts should consider the heterogeneity of risk profiles among the young adult population. In Germany, the new coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), first appeared in January 2020. At the beginning of the pandemic, high incidence rates were primarily reported among the elderly population; however, the age distribution of those infected with COVID-19 began to shift when numbers started to increase significantly among the younger population in late summer 2020 [1] [2] [3] . Since the start of the pandemic, there have been ongoing debates about COVID-19 susceptibility in young adults; however, empirical evidence remains scare and often inconclusive [4] [5] [6] . In this context, the use of seroprevalence studies, which assess the number of people in a population who test positive for a specific disease based on blood serum, can help to determine the number of infections at the population level and to identify the magnitude of undetected cases. Currently, however, most SARS-CoV-2 seroprevalence studies have focussed on the general population or on specific highrisk groups (e.g. hospital staff) [7, 8] , and only a few studies have considered young adults [4] . In some studies, the sample size was too small to enable age group-specific evaluations and in the larger studies young adults were frequently not considered as a separate group [9] [10] [11] . In studies that did evaluate young adults, only descriptive analyses were conducted; [8, 12] for example, findings from Europe determined the seroprevalence for individual age groups and found that it was highest among 20 -34- year-olds [8, 12] . To the best of our knowledge, to date, more in-depth studies among young adults have not been carried out. Many previous studies were conducted during the first pandemic wave, at a time when the COVID-19 incidence was relatively low among young people. From a public health perspective, data on SARS-CoV-2 seroprevalence among young adults is of great importance for several reasons, including: (1) young adults are characterised by a high number of asymptomatic cases, which may contribute to the undetected transmissions of the disease [13] ; (2) young adults are characterised by distinct determinants, including low-risk perception and high mobility [13, 14] ; and (3) although most young adults experience a mild disease course, there are increasing concerns of long-term adverse health effects [15] and identifying factors linked to infection risk (both detected and undetected) can help to understand SARS-CoV-2 transmission dynamics and consequently support the development of targeted prevention measures. The present study aims to provide evidence on SARS-CoV-2 seroprevalence among young adults in Germany in November 2020 (i.e. during the second pandemic wave in Germany) and to explore determinants associated with seropositivity in general and, specifically, with previously undetected infections. The STROBE checklist for reporting cross-sectional studies was followed in the present study [16] . SERODUS is a population-based, cross-sectional seroepidemiological study, which was conducted in Düsseldorf (Germany) between 2 and 27 November 2020. The sampling frame consisted of all individuals aged 18-30 years who were registered in Düsseldorf in October 2020 (n = 106,449). The study sample was selected via random sampling through the population registry ( Figure 1 ). The minimum sample size was calculated to be 1600-2000 individuals, with 95% confidence limits and assuming an anticipated seroprevalence of 1-6% or lower. The anticipated seroprevalence of 1-6% was chosen based on earlier reports that suggested a SARS-CoV-2 seroprevalence of between 1% and 6% in the general adult population [17] [18] [19] . To estimate even simple group differences with acceptable error intervals, the target corridor was a net sample of 2000 ± 400 individuals. Inclusion criteria were (i) permanent residence in Düsseldorf, (ii) aged 18-30 years at that date when the serum sample was taken and (iii) providing written informed consent. All potential participants were invited through written personal postal invitation letters (step 1) sent to their private mailboxes, including information about the study, a personal invitation number and a link to the study website. If interested in participation, an appointment could be made via the study hotline. Given the short recruitment phase of 14 days, reminder letters were sent out 5 days after the initial invitation (step 2). A total of 2189 individuals attended the study centre ( Figure 1 ). Three observations were excluded because the individuals could not be tested (e.g. syncope). This yielded an analytic sample of 2186 individuals (24% of those invited) with complete records (i.e. informed consent, questionnaire and laboratory results) ( Figure 1) . Table 1 shows the sociodemographic characteristics and Table 2 shows the health-and behaviour-related characteristics of the study participants. Of 2186 participants, 60.7% were female, 37.2% were aged 20-25 years and 16.9% had a migration background ( Table 1 ). The majority of participants rated their health as good (81%) and chronic conditions were rare, with only 9.2% of participants reporting having one or more chronic conditions ( Table 2 ). - Table 1 here -- Table 2 here - Of 2186 young adults who participated in the current study, a total of 72 individuals were seropositive, representing a crude prevalence rate of 3.3% (95% confidence interval [CI]: 2.6-4.1) and a test-adjusted prevalence of 3.1% (95% CI: 2.4-4.0) ( Table 3 ). The cumulative incidence of reported cases in the population aged 18-30 years was 1.8% (as of November 2020). Based on the estimated test-adjusted seroprevalence of 3.1% and the cumulative incidence of 1.8%, it is estimated that approximately 1.7fold more infections occurred than were ascertained by confirmed case counts. Only 31 (43.1%) of individuals with antibodies had tested positive for COVID-19 by PCR prior to the present study. Consequently, the within-study 'true' rate of unreported COVID-19 cases in this population is 2.3. Among the 72 seropositive individuals, neutralising antibodies were detected in 66 individuals (91.7%) ( Table 3 ). - Table 3 here - Table 4 and Table S2 provide a detailed presentation of seroprevalence by sociodemographic and health- (Table S2 ). The odds of being seropositive were also almost two times higher for those who seek COVID-19-related information from social media J o u r n a l P r e -p r o o f (Table S2 ; OR: 1.83, 95% CI: 1.2-3.1). An increasing trend was seen in individuals who trust information from social media influencers (OR: 1.78, 95% CI: 0.9-3.3) and who do not support social distancing (Table S2 ; OR: 1.81, 95% CI: 0.9-3.7). Unexpectedly, we did not find evidence for a significant association between low self-reported general adherence to COVID-19 public health measures and seroprevalence (Table S2 ; OR: 0.91, 95% CI: 0.5-1.5) or for participants who had travelled both within (Table S2 ; OR: 0.98, 95% CI: 0.6-1.6) and outside (Table S2; Table 4 and Table S2 also show a subgroup analysis of participants who were seropositive but did not report a prior SARS-CoV-2 infection (right column). Due to the small sample size, ORs were not calculated and the interpretation is based exclusively on the 95% CIs. The analysis showed that undetected infections are about twice as likely in men (2.6%, 95% CI: 1.7-3.99) than in women (1.3%, 95% CI: 0.7-2.0). The seroprevalence estimate was also considerably higher among individuals who did not adhere to social distancing (2.9%, 95% CI: 1.2-6.3) compared with individuals who adhered to social distancing (1.6%, 95% CI: 1.1-2.3), and among those who seek COVID-19-related information from social media (2.5%, 95% CI: 1.6-4.3) compared to those who did not seek COVID-19-related information from social media (1.3%, 95% CI: 0.8-2.1). The seroprevalence estimate was also higher in individuals who had considered SARS-CoV-2 testing in the past but ultimately did not go ahead with testing. Specifically, while 1.7% of total participants had an undetected infection, 5.0% (95% CI: 2.6-9.1) of those who had considered being tested and 5.4% (95% CI: 2.0-13.3) of those who had not received a test despite requesting one, were seropositive. Higher prevalence estimates were also found for individuals who attended an event with >50 people (2.4%, 95% CI: 1.6-3.8) and who travelled outside the EU (2.3%, 95% CI: 0.9-5.1). - Table 4 here - In the present study, a test-adjusted SARS-CoV-2 seroprevalence of 3.1% and an under-ascertainment factor of 1.7 was found among young adults in Germany. Factors significantly associated with SARS-CoV-2 seroprevalence included self-reported symptoms (e.g. loss of smell) and seeking COVID-19related information from social media. Factors significantly associated with an undetected SARS-CoV-Compared with estimates from previous national and international studies, the reported seroprevalence and under-ascertainment rate in the current study are lower than in the general adult population [24, 25] . For example, a study from the US determined a test-adjusted seroprevalence as high as 23% in some counties [24] and, in Germany, Neuhauser et al. reported an under-ascertainment factor between 2 and 6 [25] . There are at least two possibilities that might explain the observed differences. First, most studies focused on different age groups and specific population groups, such as healthcare personnel. [7, 26, 27] Furthermore, younger people often experience an asymptomatic or mild SARS-CoV-2 infection, which is associated with lower serum titres [28]. Consequently, it is possible that younger individuals have titres that fall below the threshold of serological assays and therefore previous infection may be less frequently detected. Second, the majority of studies were conducted at different times of the pandemic and often in hotspot areas [10, [29] [30] [31] ; it should be noted that the timing of the study is crucial as seroprevalence rates may vary between different pandemic phases. Specifically, many previous seroprevalence studies were performed during the first pandemic wave in spring 2020. In Germany, during this time, significantly fewer PCR tests were performed than during the second wave (starting in November 2020) and, therefore, it is likely that at the beginning of the pandemic, a much higher rate of COVID-19 cases remained undetected. Furthermore, it is important to note that to correct the seroprevalence for test sensitivity and specificity, this study applied a conservative approach by using very high sensitivity and specificity values; thus, the corrected seroprevalence is lower than the uncorrected seroprevalence. However, if sensitivity and specificity were below the manufacturer's specification, seroprevalence would be higher and the underreporting rate more distinct. Additionally, it has been suggested that antibody titres decline over time [32] . We cannot exclude the possibility that some antibody responses no longer existed by the time of the survey, which would consequently underestimate the seroprevalence. Potential determinants for seropositivity and undetected infection included self-reported symptoms and seeking COVID-19-related information from social media. The findings regarding self-reported symptoms are in line with previous reports, which show that a loss of smell and taste, as well as a fever ≥38°C were the most strongly associated factors with SARS-CoV-2 seropositivity [26, 33, 34] . Martínez et al., [34] for instance, found that fever was among the most frequently described symptoms by seropositive individuals. The results regarding social media use are novel. Currently, most studies investigating social media use in times of COVID-19 focused on preventive behaviour in general [35, 36] , but have not associated it with the actual SARS-CoV-2 seropositivity. Nonetheless, the results are somewhat contradictory with the findings of the current study. For example, Mahmood and colleagues [35] found that social media use predicts self-efficacy and perceived threat of COVID-19, which, in turn, predicts preventive behaviour. However, in the current study, participants who sought COVID-19-related information from J o u r n a l P r e -p r o o f social media were found to be significantly more likely to be seropositive, and undetected cases in this group were almost twice as likely. It is possible that seropositive individuals in the current study viewed content that downplayed the COVID-19 infection risk, which may have led to lower adherence levels to public health measures. However, this remains speculative as these interrelations could not be detected in the present study. Furthermore, it is important to note that these results may vary over time, might be wave sensitive (i.e. severity of this specific pandemic wave) and depend on information available and consequent knowledge about COVID-19. Nevertheless, social media platforms can play a critical role in the spread of information, particularly in times of crisis, and might impact adherence to public health recommendations [37, 38] . Furthermore, given that social media platforms are often the main vehicle for communication among young adults, understanding the dynamics between content consumption and social behaviour may help design more effective communication strategies. The present study did not find statistically significant results for the association between general adherence to COVID-19 public health measures and seropositivity. However, there was a tendency for seropositivity among individuals who reported that they were in support of social distancing. This may seem surprising at first but could be explained by the fact that adherence to prevention measures was retrospectively assessed. Therefore, information, recall bias and social desirability bias cannot be ruled out [27] . Nonetheless, given that social distancing effectively reduces the risk of transmission and that young adults, despite their often mild disease course, can still spread the virus, they represent a subgroup of the population requiring additional attention from public health campaigns [39] . The present study shows that large-scale COVID-19 testing can help to detect more COVID-19 cases. The expansion and continuous development of testing is recommended to secure the containment of the pandemic. Furthermore, vaccination is also essential in younger age groups, especially as recent crosssectional data from adolescents and young adults found evidence of new or persisting COVID-19 symptoms, such as fatigue, insomnia, headache, concentration difficulties, exercise intolerance and chest pain, one-month post-diagnosis [40, 41] . Vaccinating young adults may, therefore, help prevent the long-term health effects of COVID-19. Furthermore, recent evidence also suggests that vaccination can help reduce the transmission of the disease [42] . Given the high mobility of young adults, increasing immunisation in this population group can help prevent transmission, thereby also protecting vulnerable groups, such as the elderly. The current study has some limitations that must be noted. First, we aimed to explore the association between specific (social) determinants and seropositivity, but the subgroups were relatively small, which unfortunately precluded detailed and robust statistical analysis. Second, the response rate of 24% was lower than that of other seroprevalence studies, [25, 31] but higher than an epidemiological study conducted in Germany (i.e. NAKO) [43] . Nonetheless, the response rates J o u r n a l P r e -p r o o f of the other seroprevalence studies are only comparable to a limited extent since different groups were investigated and many studies focused on hotspot areas [30] . The recruitment period of the current study was short (14 days), resulting in a limited number of individuals being available to participate (i.e. recruitment could not be fully completed in every format [e.g. telephone recruitment attempts]); however, it did enable calculation of SARS-CoV-2 seroprevalence at a specific point in time. Third, it is impossible to gauge whether study participants were subject to systematic bias because contact could not be established with some invitees. A comparison with the age and gender structure of the population reveals that the net sample is well represented in terms of age, but not gender. Similar to other seroprevalence studies, men were underrepresented [10, 44] . However, since men often have a higher seroprevalence and more undetected infections, it is possible that the overall seroprevalence is underestimated in the current study. Last, sampling bias may have also occurred. Specifically, the prevalence of COVID-19 infection was higher in this study than the officially reported cumulative prevalence. While the official reported cumulative prevalence among young adults was 1.8%, in the present study 2.1% of participants reported a prior COVID-19 infection. It is likely that individuals with a prior infection were more sensitised and had an increased interest in participating. In conclusion, the findings of this study suggest that the SARS-CoV-2 seroprevalence is likely to be much higher than the reported prevalence rates based on confirmed COVID-19 cases. The results further suggest that social media plays an important role in young adults' risk perception. Given the limited amount of seroepidemiological data for young adults, a follow-up study to improve the understanding of SARS-CoV-2 seroprevalence and to better identify determinants of a SARS-CoV-2 infection is needed. J o u r n a l P r e -p r o o f Age differential analysis of COVID-19 second wave in Europe reveals highest incidence among young adults COVID-19 Trends Among Persons Aged 0-24 Years -United States Täglicher Lagebericht des RKI zur Coranavirus-Krankheit-2019 (COVID-19) Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges Changing Age Distribution of the COVID-19 Pandemic -United States Age groups that sustain resurging COVID-19 epidemics in the United States Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study Seroprevalence in the US as of Age-dependent effects in the transmission and control of COVID-19 epidemics Non-compliance with COVID-19-related public health measures among young adults in Switzerland: Insights from a longitudinal cohort study SARS-CoV-2-specific B-and Tcell immunity in a population-based study of young Swedish adults The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study) Serologische Unterschungen von Blutspenden auf Antikörper gegen SARS-CoV-2 -SeBluCo-Studie Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland -Studienprotokoll von CORONA-MONITORING lokal Statistisches Bundesamt (Destatis). Demografische Standards. Statistisches Bundesamt. 2020 Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany -Study protocol of the CORONA-MONITORING lokal study Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting ESTIMATING PREVALENCE FROM THE RESULTS OF A SCREENING TEST Seroprevalence in the US as of Ergebnisse seroepidemiologischer Studien zu SARS-CoV-2 in Stichproben der Allgemeinbevölkerung und bei Blutspenderinnen und Blutspendern in Deutschland SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event Serology-and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study) Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown Social Media Use, Self-Efficacy, Perceived Threat, and Preventive Behavior in Times of COVID-19: Results of a Cross-Sectional Study in Pakistan COVID-19 information on social media and preventive behaviors: Managing the pandemic through personal responsibility The kids are not alright: A preliminary report of Post-COVID syndrome in university students Preliminary evidence on long COVID in children Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands Die Basiserhebung der NAKO Gesundheitsstudie: Teilnahme an den Untersuchungsmodulen, Qualitätssicherung und Nutzung von Sekundärdaten Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward The authors wish to thank the study participants for their contribution to the research. They also wish to thank the personnel, and past staff, at the Mitsubishi Electric Hall and the MedLog24 team.